Online enrollment was originally slated to begin this month. However, businesses may continue to sign up for the Small Business Health Options Program through paper applications, as they have been since Oct. 1, said Julie Bataille, director of the Office of Communications for the Centers for Medicare and Medicaid Services.
They will also be able to enroll using agents and brokers or directly through an insurer.
"Many of them today are already served by using agents and brokers," Bataille said.
She also said tax credits would be applied when businesses turned in their taxes.
The announcement immediately drew outcry from Republicans, who said the delay was a sign that the website is still not up to par.
Hot Net Payout Yield Companies For 2015: RLJ Lodging Trust(RLJ)
RLJ Lodging Trust is an independent equity real estate investment trust. The firm also manages real estate funds. It invests in the real estate markets of the United States. The firm primarily invests in premium-branded, focused service, and compact full-service hotels. RLJ Lodging Trust was launched in 2000 and is domiciled in Bethesda, Maryland.
Advisors' Opinion:- [By Markus Aarnio]
American Hotel Income Properties' competitors include Hospitality Properties Trust (HPT), RLJ Lodging Trust (RLJ), and Hersha Hospitality Trust (HT).
Hot Net Payout Yield Companies For 2015: NRG Yield Inc (NYLD)
NRG Yield, Inc., incorporated on December 20, 2012, serves as the primary vehicle, through which NRG Energy, Inc. will own, operate and acquire contracted renewable and conventional generation and thermal infrastructure assets. The Company owns a diversified portfolio of contracted renewable and conventional generation and thermal infrastructure assets in the United States. The Company�� contracted generation portfolio includes three natural gas or dual-fired facilities, eight utility-scale solar and wind generation facilities and two portfolios of distributed solar facilities that collectively represent 1,324 net megawatt. The Company also own thermal infrastructure assets with an aggregate steam and chilled water capacity of 1,098 net megawatt and electric generation capacity of 123 net megawatt. In December 2013, it acquired the assets of privately held Energy Systems Company.
The Company�� thermal infrastructure assets provide steam, hot water and/or chilled water, and in some instances electricity, to commercial businesses, universities, hospitals and governmental units in ten locations, principally through long-term contracts or pursuant to rates regulated by state utility commissions. The Company�� conventional operations consist of 910 net megawatt of natural gas and dual-fired generation assets, Marsh Landing and GenConn, located in the West and Northeast regions of the United States, respectively. The Company�� seven utility-scale solar generation assets generate electricity through the use of photovoltaic panels, with each facility equal to or exceeding 20 megawatt and collectively totaling 303 net megawatt of capacity. These facilities are located in Arizona, California and New Mexico, all states with attractive solar resources. The Company�� distributed solar generation facilities, which it generally define as facilities of less than 20 megawatt in operating capacity, each generate electricity through the use of photovoltaic panels.
The Company�� wind! operations are consists of the 101 megawatt South Trent wind farm located near Sweetwater, Texas. It consists of 44 Siemens 2.3 megawatt wind turbines capable, at rated capacity, of powering approximately 80,000 homes. The Company�� thermal operations are consists of district energy systems and combined heat and power plants (Energy Centers) that utilize an energy-efficient, environmentally sound method of heating and cooling buildings. These Energy Centers produce steam, hot water and/or chilled water and in some instances, electricity at a central plant.
Advisors' Opinion:- [By Richard Stavros]
The launch of these investment vehicles has been a source of excitement in the power industry, particularly with NRG Energy Inc’s (NYSE: NRG) successful initial public offering (IPO) of NRG Yield Inc (NYSE: NYLD), the firm’s YieldCo. That’s prompted a number of utilities to announce similar plans. The question is whether these new securities offer enduring value, similar to what’s happened in the traditional MLP space, or whether they’re just another way for firms to raise cash by making a cynical play for yield-starved income investors.
- [By Robert Rapier]
Early returns suggest this proposition is generating plenty of enthusiasm. When�NRG Energy�(NYSE: NRGY) became the first company to spin off a YieldCo subsidiary holding solar generating assets last July, the offering price for�NRG Yield�(NYSE: NYLD) provided for a 5.5 percent yield at the promised dividend rate. The IPO was more than 10 times oversubscribed — an indication of pent up investor demand for such offerings. Less than 11 months later, NYLD’s share price has more than doubled, so even though it has already raised its dividend the yield is down to 2.7 percent.
Top New Stocks To Watch For 2015: Kimberly-Clark Corporation(KMB)
Kimberly-Clark Corporation, together with its subsidiaries, engages in the manufacture and marketing of various health care products worldwide. The company operates in four segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. The Personal Care segment provides disposable diapers, training and youth pants, and swimpants; baby wipes; and feminine and incontinence care products, and related products. It offers its products primarily for household use under various brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, and Poise. The Consumer Tissue segment offers facial and bathroom tissue, paper towels, napkins, and related products for household use under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, and Page brands. The K-C Professional & Other segment offers facial and bathroom tissue, paper towels, napkins, wipers, and a range of safety products for the away-from-home marketplace und er Kimberly-Clark, Kleenex, Scott, WypAll, Kimtech, KleenGuard, Kimcare, and Jackson brand names. The Health Care segment offers disposable health care products, such as surgical drapes and gowns, infection control products, face masks, exam gloves, respiratory products, pain management products, and other disposable medical products under the Kimberly-Clark, Ballard, and ON-Q brand names. The company sells its products to supermarkets; mass merchandisers; drugstores; warehouse clubs; variety and department stores; retail outlets; manufacturing, lodging, office building, food service, and health care establishments; and high volume public facilities. It markets its products through wholesalers, distributors, and direct sales. The company was founded in 1872 and is based in Dallas, Texas.
Advisors' Opinion:- [By Teresa Rivas]
Shares of Kimberly-Clark (KMB) were rising 1.4% just after 3 on Tuesday, while Avon Products (AVP) was down 1.4%, a neat symmetry that reflects BMO Capital Markets��take on the two companies.
Analysts Connie Maneaty and Patrick Trucchio upgraded Kimberly to Outperform today, while downgraded Avon to Underperform.
First, the good news: Maneaty and Trucchio write that they see Kimberly-Clark�� gross margin widening by 280 basis points in the second half of next year, thanks to lower commodity costs. This leads them to raise their earnings per share estimates by 25 cents and 30 cents for 2015 and 2016, respectively, and they also boosted their target price by $9 to $125.
Highlights from the note:
We think KMB will be perceived as the safest of the multinationals. Its sales outside the US are about 55% of total; this compares to 65%-70% for Procter & Gamble (PG) and Coty (COTY) and 80%-90% for Colgate (CL), Avon and Tupperware (TUP). In general, its risk to the most volatile currencies is below average (its exposure to Eastern Europe is less than 2% of sales), though it is still translating results in Venezuela (about 3% of sales and profit) at the official rate of 6.3 VEF/$ (the parallel rate just hit 175 VEF/$) and Argentina (also 3% of sales) may devalue again. The cost of important raw materials has started to weaken; as they follow oil�� decline they could boost gross margins in 2H15. Of note, polypropylene and natural gas are off 17% 4Q-to-date; pulp prices, while not declining much, seem manageable.
By contrast, they see significant foreign exchange risk in emerging markets (especially Russia�� response to its currency problems) hampering Avon, and they are also concerned about the impact of the company�� debt covenants on its flexibility for any potential cash restructuring charges in the new year.
From the note:
AVP could have a difficult time navigating the emerging markets’ FX weakness an
- [By Dividends4Life]
Related Articles
- United Technologies Corp. (UTX) Dividend Stock Analysis
- Chevron Corporation (CVX) Dividend Stock Analysis
- Walgreen Co. (WAG) Dividend Stock Analysis
- Kimberly-Clark Co. (KMB) Dividend Stock Analysis
- More Stock Analysis - [By guruek]
According to GuruFocus Insider Data, these are the largest insider buys during the past week: Kimberly-Clark Corporation (KMB), Ecolab Inc. (ECL), Delta Air Lines Inc. (DAL), Green Mountain Coffee Roasters, Inc. (GMCR), and NiSource Inc. (NI).
Hot Net Payout Yield Companies For 2015: Retractable Technologies Inc. (RVP)
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. Its products include VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 2mL, 3mL, 5mL, and 10mL syringes; small diameter tube adapters; blood collection tube holder; allergy trays; IV safety catheters; Patient Safe syringes; Patient Safe Luer Caps; and VanishPoint blood collection set, as well as autodisable syringes. The company sells its products to healthcare providers, such as acute care hospitals, alternate care facilities, doctors� offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons. Retractable Technologies, Inc. distributes its products through a direct marketing network; and general line and specialty distributors, as well as through international distributors. The company was founded in 1994 and is headquartered in Little Elm, Texas.
Advisors' Opinion:- [By Holly LaFon]
Chip Skinner is a portfolio manager and principal of Royce & Associates, LLC, investment advisor to The Royce Funds. He serves as portfolio manager for Royce Value Plus Fund (RVP) and serves as an assistant portfolio manager for Royce Low-Priced Stock Fund (RLP). The thoughts expressed in this piece are solely those of the person speaking and may differ from those of other Royce investment professionals, or the firm as a whole. There can be no assurance with regard to future market movements.
Hot Net Payout Yield Companies For 2015: CF Industries Holdings Inc. (CF)
CF Industries Holdings, Inc., through its subsidiary, CF Industries, Inc., manufactures and distributes nitrogen and phosphate fertilizer products, serving agricultural and industrial customers worldwide. It operates in two segments, Nitrogen and Phosphate. The Nitrogen segment principally offers ammonia, granular urea, urea ammonium nitrate solution, urea liquor, diesel exhaust fluid, and aqua ammonia. The Phosphate segment primarily offers diammonium phosphate and monoammonium phosphate. The company also owns 50% interests in the GrowHow UK Limited, a nitrogen products producer in the United Kingdom; Point Lisas Nitrogen Limited, an ammonia producer; and KEYTRADE AG, a global fertilizer trading company. CF Industries Holdings� customers include cooperatives and independent fertilizer distributors primarily in the midwestern United States. The company was founded in 1946 and is headquartered in Deerfield, Illinois.
Advisors' Opinion:- [By Marc Bastow]
Nitrogen and phosphate fertilizer manufacturer CF Industries (CF) raised its quarterly dividend 150% to $1 per share, payable Nov. 29 to shareholders of record as of Nov. 15.
CF Dividend Yield: 1.85% - [By Daniela Pylypczak]
CF Industries (CF) announced on Thursday that it has raised its quarterly dividend by 150%.
Two months after activist investor Dan Loeb’s Third Point LLC hedge fund demanded the fertilizer company raise its dividend payout, CF Industries announced that it will raise its quarterly dividend from $0.40 to $1.00 per shares, or an increase from an annualized payout of $1.60 to $4.00.
The dividend will be payable on November 29,2013 to shareholders of record on November 15, 2013 with an ex-dividend date of November 13, 2013.
Commenting on the dividend hike, CEO Stephen R. Wilson noted “This dividend increase reflects our confidence in the strength of CF Industries��business model and is part of our ongoing commitment to build long term shareholder value.”
CF Industries shares traded 0.29% higher during Thursday’s session. Year-to-date, the stock is up a mere 0.82%.
Hot Net Payout Yield Companies For 2015: Herbalife Ltd (HLF)
Herbalife Ltd., incorporated on April 4, 2002, is a global network marketing company that sells weight management, nutritional supplements, energy, sports and fitness products and personal care products through a network of approximately 2.7 million independent distributors, except in China, where the Company sells its products through retail stores. The Company is a network marketing company that sells a range of weight management products, nutritional supplements and personal care products. As of December 31, 2011, the Company sold products in 79 countries throughout the world. Herbalife�� products are grouped in four principal categories: weight management, targeted nutrition, energy, sports and fitness and Outer Nutrition, along with literature and promotional items. The Company�� generates revenue from its six regions: North America, Mexico, South and Central America; EMEA, which consists of Europe, the Middle East and Africa, Asia Pacific (excluding China), and China. On December 31, 2012, the Company acquired a manufacturing facility in Winston-Salem, North Carolina.
The Company�� products are manufactured by third party providers and by the Company in its Suzhou, China facility and in its manufacturing facility located in Lake Forest, California, and then are sold to independent distributors who sell Herbalife products to retail consumers or other distributors. As of December 31, 2011, Herbalife marketed and sold 138 products encompassing over 4,400 stock keeping units (SKUs) through its distributors.
Weight Management
Weight Management is the Company�� largest product category representing 62.5% of its net sales during the year ended December 31, 2011. Formula 1, its product, is a healthy meal with soy protein, essential vitamins, minerals, herbs and nutrients that is available in seven flavors and can help support weight management. Personalized Protein Powder is a soy and whey protein product designed as a boost to Formula 1 to personalize a pe! rson�� daily protein intake to help achieve their desired weight and shape. Weight-loss enhancers, including Herbal Tea Concentrate, Total Control and Prolessa Duo address specific challenges associated with dieting, such as lack of energy, hunger and food craving, fluid retention, decreased metabolism and digestive challenges, by building energy, boosting metabolism, curbing appetite and helping to promote weight loss. Healthy snacks are formulated to provide between-meal nutrition and appetite satisfaction.
Targeted Nutrition
Herbalife markets numerous dietary and nutritional supplements designed to meet its customers��specific nutritional needs. Each of these supplements contains botanicals, vitamins, minerals and other natural ingredients and focuses on specific life stages of its customers, including women, men, children and those with health concerns, including heart health, healthy aging, digestive health, or immune solutions. Niteworks is a product that supports energy, circulatory and vascular health and enhances blood flow to the heart, brain and other vital organs. Garden 7 is designed to provide the phytonutrient benefits of seven servings of fruits and vegetables and has anti-oxidant and health-boosting properties. Best Defense is an effervescent drink that helps boost immunity. In 2011, the Company expanded distribution of its Active Fiber line by introducing its Apple flavored Active Fiber Complex in the South and Central America region.
Energy, Sports and Fitness
Herbalife entered into the energy drink with the introduction of Liftoff, an energy drink containing a blend of B-vitamins, guarana, ginseng, ginkgo and caffeine to increase energy and improve mental clarity for better performance throughout the day. It launched H3Otm Fitness Drink to provide hydration, sustained muscle energy plus antioxidant protection for people living a healthy, active lifestyle. It also introduced H30 Pro in EMEA to provide an isotonic drink to indivi! duals par! ticipating in high activity sports.
Outer Nutrition
The Company�� Outer Nutrition products complement its weight management and targeted nutrition products and aim to improve the appearance of the body, skin and hair. These products include skin cleansers, toners, moisturizers and facial masks, shampoos and conditioners, body-wash items and a selection of fragrances for men and women. Its Herbal Aloe line is its introductory line providing distributors with cleansers, lotions and soaps that help sooth the skin. NouriFusion Multivitamin skin care products are formulated with antioxidant Vitamins A, C and E. It launched a line of anti-aging products as an extension of its Skin Activator product, an advanced face cream that contains a collagen-building Glucosamine Complex to reduce the appearance of fine lines and wrinkles. It also launched a number of regional products including a Soft Green Body Care line in Brazil, the Whitening Serum under the NouriFusion brand in the Asia Pacific region, and the Lively Fragrances perfume line.
Literature, Promotional and Other Products
Herbalife also sells literature and promotional materials, including sales aids, informational audiotapes, videotapes, compact discs (CDs) and digital versatile discs (DVDs) designed to support its distributors��marketing efforts, as well as start-up kits called International Business Packs for new distributors. It introduced BizWorks, a customizable retail Website for its distributors to enhance the on-line experience.
The Company competes with NuSkin Enterprises, Nature�� Sunshine, Alticor/Amway, Melaleuca, Avon Products, Oriflame, Tupperware and Mary Kay, Weight Watchers, Jenny Craig, General Nutrition Centers and Wal-Mart.
Advisors' Opinion:- [By Selena Maranjian]
Finally, Third Point's biggest closed positions included Tesoro�and Morgan Stanley. Other closed positions of interest include Herbalife (NYSE: HLF ) and Abbott Labs. Herbalife has some high-profile critics, such as David Einhorn of Greenlight Capital and Bill Ackman of Pershing Square Capital Management, though others, such as Carl Icahn, have been buyers. The company has been reporting solid results, with its first quarter featuring revenue up 17%, net profit up 10%, and expectations for double-digit, near-term growth. Some worry about its multilevel-marketing strategy, but those who believe and are patient can collect a dividend yield near 2.5%.
- [By Matt DiLallo]
Another even more recent example is the high-profile short-sale argument against Herbalife (NYSE: HLF ) �This case also drew in the SEC as another famed short-seller had called the company "the best-managed pyramid scheme in the history of the world." Because many investors have rules to sell when the SEC is involved, it creates a lot of selling pressure as investors bail, which can make a lot of money for a short-seller.
- [By Alanna Petroff]
Shares in Herbalife (HLF) are declining by more than 10% premarket after the company posted earnings that missed analysts' forecasts.
2. European earnings: Shares in two major European banks -- UBS (UBS) and Deutsche Bank (DB) -- were under pressure after both reported earnings and flagged new litigation risks.
Hot Net Payout Yield Companies For 2015: FX Energy Inc (FXEN)
FX Energy, Inc. is an independent oil and gas exploration and production company with production, appraisal, and exploration activities in Poland. The Company operates within two segments of the oil and gas industry: the exploration and production (E&P) segment in Poland and the United States, and the oilfield services segment in the United States. The Company also has oil production, oilfield service activities, and a shale acreage position in the United States. During the year ended December 31, 2011, its oil and gas production was 4.4 billion cubic feet of natural gas (12.0 million cubic feet equivalent per day). The Company concentrates its exploration operations in Poland primarily on the Rotliegend sandstones of the Permian Basin. The Company has identified a core area consisting of approximately 852,000 gross acres surrounding PGNiG�� producing Radlin field.
Activities and Presence in Poland
The Company conducts its activities in Poland in project areas, including Fences, Blocks 287, 246, and 229 near the Fences concession, Warsaw South, Kutno, Northwest, and Edge. In the Fences during 2011, it completed the Lisewo-1 well as a commercial well and drilled the Plawce-2 well in a tight sand area. In its other concessions it drilled the Machnatka-2 well, a noncommercial Zechstein/Carboniferous test, in the Warsaw South concession, and started drilling the Kutno-2 well, a deep Rotliegend test, in the Kutno concession. The Fences concession area encompasses 852,000 gross acres (3,450 square kilometers) in western Poland�� Permian Basin. The Fences concession area encompasses 852,000 gross acres (3,450 square kilometers) in western Poland�� Permian Basin. The Company has drilled 11 conventional wells targeting Rotliegend structures through the date of this filing. Eight of these wells are commercial. The Company is produce from four of these eight wells.
The Block 287 concession area is 12,000 acres (50 square kilometers) located approximately 25 miles so! uth of the Fences concession area. The Company owns 100% of the exploration rights. As of December 31, 2011, it has reentered only the Grabowka-12 well. During 2011, it produced at an average daily rate of approximately 0.2 million cubic feet of natural gas per day. The Company has a 100% interest in a concession south of its Fences project area covering approximately 241,000 acres (975 square kilometers). The Company hold a 51% interest in a total of 874,000 acres (3,538 square kilometers.) in east-central Poland. During 2011, it entered into a farmout agreement with PGNiG under which it earned a 49% interest in the entire Warsaw South concession in return for paying certain seismic and drilling costs. It subsequently drilled the Machnatka-2 well to test Zechstein and Carboniferous potential in the western part of the concession area.
The Company holds a 100% interest in 706,000 acres (2,856 square kilometers). The area encompasses a Rotliegend structure (Kutno) with projected four-way dip closure. It started drilling the Kutno-2 well during 2011. It hold concessions on 828,000 acres (3,351 square kilometers) in west-central Poland, in Poland�� Permian Basin directly north of PGNiG�� BMB and MLG oil and gas fields. The Company has a 100% interest in four concessions in north-central Poland covering approximately 881,000 acres (3,567 square kilometers). As of December 31, 2011, it held oil and gas exploration rights in Poland in separately designated project areas encompassing approximately 4.6 million gross acres. The Company is the operator in all areas, except its 852,000 gross-acre core Fences project area, in which it hold a 49% interest in approximately 807,000 acres and a 24.5% interest in the remaining 45,000 acres.
U.S. Activities and Presence
The operations consist of shallow, oil-producing wells in the Southwest Cut Bank Sand Unit (SWCBSU), of Montana. Its oil wells produce approximately 155 barrels of oil per day, net to its interest. From its fie! ld office! in Montana, the Company also provides oilfield services. The Company produces oil from approximately 10,732 gross (10,418 net) acres in Montana and 400 gross (128 net) acres in Nevada. In 2011, the Company entered into a joint venture with two other companies, American Eagle Energy, Inc., and Big Sky Operating LLC, in which it pooled our approximately 10,000 net acres in our SWCBSU with their approximately 65,000 net acres, the Americana leases, along with a farmout agreement that provides the group with an ability to earn an interest in an additional 7,000 acres covered by the Somont leases. During 2011, it drilled three vertical wells on joint venture acreage to obtain log and core data. The Company also drilled a 3,600-foot lateral from one of these three wells, the Anderson 14-29, and carried out a multistage fracture. The Company is testing oil potential in the Anderson 14-29 well. The Company has a one-third working interest in all formations below the Cut Bank in its SWCBSU.
Advisors' Opinion:- [By Roberto Pedone]
Another energy player that's starting to trend within range of triggering a major breakout trade is FX Energy (FXEN), which is an independent oil and gas exploration and production company with principal production, reserves and exploration in Poland and oil production, oilfield service and exploration activities in the U.S. This stock is off to a slow start in 2013, with shares off by 14%.
If you take a look at the chart for FX Energy, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months and change, with shares moving between $2.93 on the downside and $3.98 on the upside. Shares of FXEN are now starting to bounce higher off its 50-day moving average of $3.36 share, and it's quickly moving within range of triggering a major breakout trade above the upper-end of its recent range.
Traders should now look for long-biased trades in FXEN if it manages to break out above some key near-term overhead resistance levels at $3.62 to $3.71 a share and then above more resistance at $3.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 377,632 shares. If that breakout hits soon, then FXEN will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.76 a share. Any high-volume move above those levels will then give FXEN a chance to tag or trend above $5 a share.
Traders can look to buy FXEN off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.15 or $2.93 a share. One could also buy FXEN off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Roberto Pedone]
An under-$10 energy player that's trending very close to triggering a major breakout trade is FX Energy (FXEN), which is an independent oil and gas exploration and production company with principal production, reserves and exploration in Poland and oil production, oilfield service and exploration activities in the U.S. This stock has been under selling pressure so far in 2013, with shares off by 12.6%.
If you take a look at the chart for FX Energy, you'll notice that this stock recently formed a double bottom chart pattern at $2.82 to $2.93 a share. Following that bottom, shares of FXEN are now starting to uptrend and push back above its 50-day moving average of $3.41 a share. That move is quickly pushing shares of FXEN within range of triggering a major breakout trade above a key downtrend line that started back in late May.
Traders should now look for long-biased trades in FXEN if it manages to break out above its 200-day moving average at $3.75 a share and then once it takes out more near-term overhead resistance at $3.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 478,408 shares. If that breakout triggers soon, then FXEN will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.76 a share. Any high-volume move above those levels will then put its May high at $6.18 into range for shares of FXEN.
Traders can look to buy FXEN off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.11 to $2.93 a share. One can also buy FXEN off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By James E. Brumley]
If it seems like you've heard the market buzzing about FX Energy, Inc. (NASDAQ:FXEN) quite a bit of late, you're not crazy - it's been in the spotlight a little more than usual over the past few weeks. And for good reason. FXEN shares are about to explode higher. All they need is the right nudge. More on that in a second.
- [By Roberto Pedone]
FX Energy (FXEN) is an independent oil and gas exploration and production company with principal production, reserves and exploration in Poland and oil production, oilfield service and exploration activities in the U.S. This stock closed up 5.7% to $3.69 in Thursday's trading session.
Thursday's Range: $3.34-$3.71
52-Week Range: $2.48-$8.78
Thursday's Volume: 524,000
Three-Month Average Volume: 672,515From a technical perspective, FXEN bounced notably higher here right above some near-term support at $3.31 and back above its 50-day moving average of $3.66 with decent upside volume. This move is quickly pushing shares of FXEN within range of triggering a near-term breakout trade. That trade will hit if FXEN manages to take out some near-term overhead resistance levels at its 200-day moving average of $3.89 to more resistance at $3.98.
Traders should now look for long-biased trades in FXEN as long as it's trending above support at $3.31 and then once it sustains a move or close above those breakout levels with volume that hits near or above 672,515 shares. If that breakout triggers soon, then FXEN will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.76. Any high-volume move above those levels will then put its recent high at $5 into range for shares of FXEN.
Hot Net Payout Yield Companies For 2015: Hospira Inc (HSP)
Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.
Specialty Injectable Pharmaceuticals
Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.
Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.
Other Pharmaceuticals
Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.
Medication Management
Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.
Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.
The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.
Advisors' Opinion:- [By Ben Levisohn]
That decision has helped make Allergan the top performing pharmaceutical stock in the S&P 500. Its shares have gained 4.3% to $108.18, today at 2:32 p.m., besting Merck’s (MRK) 1.2% rise to $49.36, Mylan’s (MYL) 1.1% advance to $42.98, Hospira’s (HSP) 0.7% increase to $41.34 and Eli Lily’s (LLY) 0.6% rise to $50.42.
- [By Sean Williams]
Drug developer Hospira (NYSE: HSP ) also had a notably impressive day, advancing 6% after receiving a positive opinion on inflectra in Europe. Designed to treat rheumatoid arthritis, inflammatory bowel disease, and plaque psoriasis, inflectra, a biosimilar of Johnson & Johnson's�Remicade, received a positive opinion from the Committee for Medicinal Products for Human Use, meaning it would recommend the European Medicines Agency to approve the drug. This could be a key win for Hospira, because J&J's Remicade was responsible for roughly $6 billion in annual revenue, and could be a huge bottom-line boost for Hospira.
Hot Net Payout Yield Companies For 2015: Sonus Networks Inc.(SONS)
Sonus Networks, Inc. provides voice and multimedia infrastructure solutions. The company offers session border control (SBC), voice over Internet protocol (VoIP), and access and VoIP media gateway solutions that allow the delivery of voice and multimedia sessions over IP networks. Its products include GSX9000 Open Services Switch that enables voice traffic to be transported over packet networks; GSX4000 Open Services Switch; NBS9000 Network Border Switch that permits service providers to transform their time division multiplexing networks to IP; PSX Policy & Routing Server, which translates business policies into actual call control, routing, and service selection decisions; NBS5200 Network Border Switch that provides SBC functionality; and ASX Call Feature Server that provides local area calling and regulatory features for residential and enterprise markets. The company also offers Network Analytics Suite of performance management products, including NetScore network perf ormance analysis tool, NetAssure voice quality monitoring tool, and NetEng network audit and visualization engine that are used for the collection, monitoring, reporting, and notification of performance metrics. In addition, it provides professional consulting and services to support its IP communication solutions; and program management, network deployment design, softswitch and subscriber database design, network verification and audit, custom application and adaptor development, OSS and API integration, migration and upgrade, and managed services. The company serves long-distance and local exchange carriers, Internet service providers, wireless operators, cable operators, financial institutions, retailers, state and local governments, and multinational corporations. It sells its products primarily through a direct sales force in the United States, Europe, the Asia-Pacific, and the Middle East. Sonus Networks, Inc. was founded in 1997 and is headquartered in Westford, Mass achusetts.
Advisors' Opinion:- [By Lee Jackson]
Sonus Networks Inc. (NASDAQ: SONS) was recently named to the 2013 InformationWeek 500 list of top technology innovators across the country. In July the company authorized a repurchase program to buy back up to $100 million of their stock. Lazard has a Buy rating on the stock and a $4.50 price target. The consensus target is at $4.30, and the stock closed yesterday at $3.41.
- [By Evan Niu, CFA]
What: Shares of Sonus Networks (NASDAQ: SONS ) have popped today by upwards of 17% after the company reported first-quarter earnings.
So what: First quarter sales totaled $63.3 million, which turned into a non-GAAP net loss of $0.02 per share. Investors were expecting just $61.1 million up top and an adjusted loss of $0.03 per share, meaning the figures were a beat relative to consensus estimates. Session border controller, or SBC, revenue was up 77% to $30 million.
- [By Ben Fox Rubin]
Sonus Networks Inc.(SONS) agreed to buy Performance Technologies Inc.(PTIX), a supplier of network communications products, for $3.75 a share, a 26% premium of Thursday’s close, or $42 million. The companies said the deal was worth $30 million, net of Performance Technologies’ cash and excluding acquisition costs. Performance Technologies shares jumped 24% to $3.70 premarket, just under the offer price.
- [By Roberto Pedone]
One networking player that's starting to move within range of triggering a big breakout trade is Sonus Networks (SONS), which provides networked solutions for communications service providers and enterprises in the U.S., Europe, the Middle East, Africa, and the Asia Pacific. This stock has been red hot so far in 2013, with shares up 104%.
If you take a look at the chart for Sonus Networks, you'll notice that this stock has been trending sideways for the past month, with shares moving between $3.25 on the downside and $3.72 on the upside. Shares of SONS have been finding support over the last month each time the stock has pulled back to its 50-day moving average. This stock is now starting to trend a bit higher and move within range of triggering a breakout trade above the upper-end of its sideways consolidating chart pattern.
Traders should now look for long-biased trades in SONS if it manages to break out above some near-term overhead resistance at $3.56 to $3.59 a share and then once it takes out its 52-week high at $3.72 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2.50 million shares. If that breakout hits soon, then SONS will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $5 to $5.50 a share.
Traders can look to buy SONS off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.33 to $3.25 a share, or right below more support at $3.10 a share. One could also buy SONS off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Hot Net Payout Yield Companies For 2015: Pharma-Bio Serv Inc (PBSV.PK)
Pharma-Bio Serv, Inc.( Pharma-Bio), incorporated on June 8, 2006, is a compliance and technology transfer services consulting firm with a laboratory testing facility, servicing the Puerto Rico, United States and Europe markets. The Company is engaged in providing technical compliance consulting service, and microbiological and chemical laboratory testing services primarily to the pharmaceutical, chemical, medical device and biotechnology industries. The Company�� operating segments include Puerto Rico technical compliance consulting, United States technical compliance consulting, Ireland technical compliance consulting and a Puerto Rico microbiological and chemical laboratory testing division (Lab). These segments provide services primarily to the pharmaceutical, chemical, medical device and biotechnology industries in their respective markets. As on April 30, 2012, the Company acquired 100% interest in its subsidiary, Pharma-IR.
The Company provides a broad range of compliance related consulting services. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It provides information technology consulting services and technical training/seminars. The Company offers services to its core industries already serviced as well as the cosmetic and food industries. The Company seeks opportunities in markets that could yield profitable margins using its professional consulting force and also provide services such as those performed by its microbiological testing laboratory facility, its information technology service division, Integratek, and its technical training division, Pharma Serv Academy.
The Company�� information technology services and consulting division based in Puerto Rico (Integratek) provides a variety of information technology services, such as Web pages and portals development, digital art design, intranets, extranets, software development including database integration, Window! s and Web applications development, software technical training and learning management systems, technology project management, and compliance consulting services, among others.
Advisors' Opinion:- [By The Specialist]
Normally when one of my stocks reports its earnings results after hours on a Friday, I cringe in anticipation of a bad report. Normally Friday after hours is a time slot reserved for companies who have disappointing results to deliver and wish to stay off radar. Naturally, when I got the alert on a Friday afternoon that Pharma-Bio Serv (PBSV.PK) had just reported its earnings results, I had one eye shut when opening the press release, fearing what would be inside.
No comments:
Post a Comment